178 related articles for article (PubMed ID: 21130877)
1. Genome-wide expression studies in autism spectrum disorder, Rett syndrome, and Down syndrome.
Lintas C; Sacco R; Persico AM
Neurobiol Dis; 2012 Jan; 45(1):57-68. PubMed ID: 21130877
[TBL] [Abstract][Full Text] [Related]
2. Rett syndrome: of girls and mice--lessons for regression in autism.
Glaze DG
Ment Retard Dev Disabil Res Rev; 2004; 10(2):154-8. PubMed ID: 15362175
[TBL] [Abstract][Full Text] [Related]
3. Dysregulated brain immunity and neurotrophin signaling in Rett syndrome and autism spectrum disorders.
Theoharides TC; Athanassiou M; Panagiotidou S; Doyle R
J Neuroimmunol; 2015 Feb; 279():33-8. PubMed ID: 25669997
[TBL] [Abstract][Full Text] [Related]
4. Loud and clear evidence for gene silencing by epigenetic mechanisms in autism spectrum and related neurodevelopmental disorders.
Lopez-Rangel E; Lewis ME
Clin Genet; 2006 Jan; 69(1):21-2. PubMed ID: 16451129
[No Abstract] [Full Text] [Related]
5. Rett syndrome: a prototypical neurodevelopmental disorder.
Neul JL; Zoghbi HY
Neuroscientist; 2004 Apr; 10(2):118-28. PubMed ID: 15070486
[TBL] [Abstract][Full Text] [Related]
6. Autism spectrum disorders and epigenetics.
Grafodatskaya D; Chung B; Szatmari P; Weksberg R
J Am Acad Child Adolesc Psychiatry; 2010 Aug; 49(8):794-809. PubMed ID: 20643313
[TBL] [Abstract][Full Text] [Related]
7. Pathways to drug development for autism spectrum disorders.
Hampson DR; Gholizadeh S; Pacey LK
Clin Pharmacol Ther; 2012 Feb; 91(2):189-200. PubMed ID: 22205199
[TBL] [Abstract][Full Text] [Related]
8. Genomic and transcriptomic analyses distinguish classic Rett and Rett-like syndrome and reveals shared altered pathways.
Colak D; Al-Dhalaan H; Nester M; Albakheet A; Al-Younes B; Al-Hassnan Z; Al-Dosari M; Chedrawi A; Al-Owain M; Abudheim N; Al-Alwan L; Al-Odaib A; Ozand P; Inan MS; Kaya N
Genomics; 2011 Jan; 97(1):19-28. PubMed ID: 20934504
[TBL] [Abstract][Full Text] [Related]
9. Two genetic variants of CD38 in subjects with autism spectrum disorder and controls.
Munesue T; Yokoyama S; Nakamura K; Anitha A; Yamada K; Hayashi K; Asaka T; Liu HX; Jin D; Koizumi K; Islam MS; Huang JJ; Ma WJ; Kim UH; Kim SJ; Park K; Kim D; Kikuchi M; Ono Y; Nakatani H; Suda S; Miyachi T; Hirai H; Salmina A; Pichugina YA; Soumarokov AA; Takei N; Mori N; Tsujii M; Sugiyama T; Yagi K; Yamagishi M; Sasaki T; Yamasue H; Kato N; Hashimoto R; Taniike M; Hayashi Y; Hamada J; Suzuki S; Ooi A; Noda M; Kamiyama Y; Kido MA; Lopatina O; Hashii M; Amina S; Malavasi F; Huang EJ; Zhang J; Shimizu N; Yoshikawa T; Matsushima A; Minabe Y; Higashida H
Neurosci Res; 2010 Jun; 67(2):181-91. PubMed ID: 20435366
[TBL] [Abstract][Full Text] [Related]
10. Identification of a functional rare variant in autism using genome-wide screen for monoallelic expression.
Ben-David E; Granot-Hershkovitz E; Monderer-Rothkoff G; Lerer E; Levi S; Yaari M; Ebstein RP; Yirmiya N; Shifman S
Hum Mol Genet; 2011 Sep; 20(18):3632-41. PubMed ID: 21680558
[TBL] [Abstract][Full Text] [Related]
11. The GABAA Receptor as a Therapeutic Target for Neurodevelopmental Disorders.
Braat S; Kooy RF
Neuron; 2015 Jun; 86(5):1119-30. PubMed ID: 26050032
[TBL] [Abstract][Full Text] [Related]
12. [Clinical characteristics of Rett Syndrome].
Abbes Z; Bouden A; Halayem S; Othman S; Bechir Halayem M
Tunis Med; 2011 Oct; 89(10):733-7. PubMed ID: 22076893
[TBL] [Abstract][Full Text] [Related]
13. Altered calcium homeostasis in autism-spectrum disorders: evidence from biochemical and genetic studies of the mitochondrial aspartate/glutamate carrier AGC1.
Palmieri L; Papaleo V; Porcelli V; Scarcia P; Gaita L; Sacco R; Hager J; Rousseau F; Curatolo P; Manzi B; Militerni R; Bravaccio C; Trillo S; Schneider C; Melmed R; Elia M; Lenti C; Saccani M; Pascucci T; Puglisi-Allegra S; Reichelt KL; Persico AM
Mol Psychiatry; 2010 Jan; 15(1):38-52. PubMed ID: 18607376
[TBL] [Abstract][Full Text] [Related]
14. The story of Rett syndrome: from clinic to neurobiology.
Chahrour M; Zoghbi HY
Neuron; 2007 Nov; 56(3):422-37. PubMed ID: 17988628
[TBL] [Abstract][Full Text] [Related]
15. A review on cognitive and brain endophenotypes that may be common in autism spectrum disorder and attention-deficit/hyperactivity disorder and facilitate the search for pleiotropic genes.
Rommelse NN; Geurts HM; Franke B; Buitelaar JK; Hartman CA
Neurosci Biobehav Rev; 2011 May; 35(6):1363-96. PubMed ID: 21382410
[TBL] [Abstract][Full Text] [Related]
16. [Autism and epigenetics. A model of explanation for the understanding of the genesis in autism spectrum disorders].
Arberas C; Ruggieri V
Medicina (B Aires); 2013; 73 Suppl 1():20-9. PubMed ID: 24072048
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial dysfunction as a central actor in intellectual disability-related diseases: an overview of Down syndrome, autism, Fragile X and Rett syndrome.
Valenti D; de Bari L; De Filippis B; Henrion-Caude A; Vacca RA
Neurosci Biobehav Rev; 2014 Oct; 46 Pt 2():202-17. PubMed ID: 24548784
[TBL] [Abstract][Full Text] [Related]
18. [Rett syndrome: clinical and molecular aspects].
Záhoráková D; Zeman J; Martásek P
Cas Lek Cesk; 2007; 146(8):647-52. PubMed ID: 17874730
[TBL] [Abstract][Full Text] [Related]
19. The role of calcium-dependent gene expression in autism spectrum disorders: lessons from MeCP2, Ube3a and beyond.
Qiu Z; Cheng J
Neurosignals; 2010; 18(2):72-81. PubMed ID: 20956852
[TBL] [Abstract][Full Text] [Related]
20. Spectrum of MECP2 mutations in New Zealand Rett syndrome patients.
Raizis AM; Saleem M; MacKay R; George PM
N Z Med J; 2009 Jun; 122(1296):21-8. PubMed ID: 19652677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
